Craft
  • Home
  •  / IFM Therapeutics
IFM Therapeutics

IFM Therapeutics

Total Funding

$82.5 M

IFM Therapeutics Summary

Company summary

Overview
IFM Therapeutics is a biopharmaceutical company. It is focused on the research and development of biological treatments for inflammatory diseases and cancer. The company's mission is to improve the lives of patients by developing small molecule drugs that target the innate immune system.
Type
Private
Status
Active
Founded
2017
HQ
Boston, MA, US | view all locations
Website
https://www.ifmthera.com/
Cybersecurity rating
Sectors

Key people

  • Martin Seidel

    Martin Seidel, Chief Executive Officer

    • Dennis Dean

      Dennis Dean, Chief Development Officer

      • William R. Roush

        William R. Roush, Executive Vice President of Chemistry

        • Ed Olhava

          Ed Olhava, Senior Vice President of Preclinical Development

          LocationsView all

          1 location detected

          • Boston, MA HQ

            United States

            855 Boylston St 11th floor

          News

          Footer menu